Stay updated on Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:23.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a small maintenance update with no visible changes to study data.
    Difference
    0.1%
    Check dated 2026-03-11T14:04:04.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    System updates show Revision: v3.4.2 added and prior notices about funding and operating status (Revision: v3.4.1) present in the deletions. These changes relate to site maintenance and do not modify the trial record details, outcomes, or recruitment information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:59:57.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page to Revision: v3.4.1 (from v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-03T23:40:00.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Footer/UI updates add a 'Show glossary' option, adjust the 'No FEAR Act Data' label capitalization, and update the site revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T22:35:59.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link as well as the Revision: v3.3.2 reference. These changes do not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:23:23.000Z thumbnail image

Stay in the know with updates to Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.